(3-hydroxy-[1,1'-biphenyl]-4-yl)(phenyl)methanone | 51531-18-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (3-hydroxy-[1,1'-biphenyl]-4-yl)(phenyl)methanone
• 英文别名: (2-Hydroxy-4-phenylphenyl)-phenylmethanone
• CAS: 51531-18-1
• 化学式: C₁₉H₁₄O₂
• 分子量: 274.319
• InChiKey: UOTWKQHDGYWIRT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.1
• 重原子数：
  21
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (3-hydroxy-[1,1'-biphenyl]-4-yl)(phenyl)methanone 在 氨 作用下， 以 甲醇 为溶剂， 反应 16.0h， 以100%的产率得到4-(imino(phenyl)methyl)-[1,1'-biphenyl]-3-ol
  参考文献：
  名称：

  手性磷酸催化对羟基二苯甲酮N ？的对映选择性加氢 H Ketimines及其应用

  摘要：

  未受保护的合成：第一对映选择性的手性磷酸催化的传递未受保护的氢化邻-hydroxybenzophenoneÑ  ħ亚胺通过使用汉奇酯作为得到相应的手性氢源N，O -unprotected邻-hydroxydiarylmethylamines以高收率和优异的对映选择性（见方案）。

  DOI：

  10.1002/chem.201101694
• 作为产物：
  描述：

  3-联苯硼酸 在 吡啶 、 dipotassium peroxodisulfate 、 dichloro(pentamethylcyclopentadienyl)rhodium (III) dimer 、 cesium acetate 、 sodium carbonate 、 一水合肼 、 silver carbonate 、 copper(l) chloride 作用下， 以 甲醇 、 氯仿 、 水 、 乙酸乙酯 、 1,2-二氯乙烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 27.0h， 生成 (3-hydroxy-[1,1'-biphenyl]-4-yl)(phenyl)methanone
  参考文献：
  名称：

  RhIII催化带有氧化导向基团的芳烃的脱羧邻酰基化

  摘要：

  我们提出了Rh III催化的芳烃脱羧酰化的第一份报告。这种方法可以有效地选择性地获得单/双邻位酰化苯酚。通常，对于对位取代的N-芳氧基乙酰胺，可以通过改变氧化剂的量来控制产物对单酰化和双酰化苯酚的选择性。但是在任何条件下，邻位和间位取代的N-芳氧基乙酰胺都可以提供独家的单酰化产物。

  DOI：

  10.1002/ejoc.201900242

文献信息

• Modulators of peroxisome proliferator activated receptors
  申请人：Brooks Alisa Dawn

  公开号：US20050020684A1

  公开（公告）日：2005-01-27

  Disclosed is a compound represented by Structural Formula (I): Ar is a substituted or unsubstituted aromatic group. Q is a covalent bond, —CH 2 — or —CH 2 CH 2 —; W is a substituted or unsubstituted alkylene or a substituted or unsubstituted heteroalkylene linking group from two to ten atoms in length, preferably from two to seven atoms in length. Phenyl Ring A is optionally substituted with up to four substituents in addition to R 1 and W, R 2 is (CH 2 ) n —CH(OR 2 )—(CH 2 ) n E, —(CH)═C(OR 2 )—(CH 2 ) n E, —(CH 2 ) n —CH(Y)—(CH 2 ) m E or (CH)═C(Y)(CH 2 ) m E; wherein E is COOR 3 , C 1 -C 3 alkylnitrile, carboxamide, sulfonamide, acylsulfonamide or tetrazole and wherein sulfonamide, acylsulfonamide and tetrazole are optionally substituted with one or more substituents independently selected from: C 1 -C 6 alkyl, haloalkyl and aryl-C o - 4 -alkyl; R 2 is H, an aliphatic group, a substituted aliphatic group, haloalkyl, an aromatic group, a substituted aromatic group, —COR 4 , —COOR 4 , —CONR 5 R 6 , —C(S)R 4 , —C(S)OR 4 or C(S)NR 5 R 6 , R 3 is H, an aliphatic group, a substituted aliphatic group, an aromatic group or a substituted aromatic group. Y is O—, CH 2 —, CH 2 CH 2 — or CH═CH— and is bonded to a carbon atom in Phenyl Ring A that is ortho to R 1 . R 4 -R 6 are independently H, an aliphatic group, a substituted aliphatic group, an aromatic group or a substituted aromatic group. n and m are independently 0, 1 or 2.

  本发明公开了一种由结构式（I）表示的化合物：其中Ar是取代或未取代的芳香基团。Q是共价键，-CH2-或-CH2CH2-; W是取代或未取代的烷基或取代或未取代的异烷基连接基，长度为两到十个原子，优选长度为两到七个原子。苯环A可选地与R1和W以外的最多四个取代基取代，R2是（CH2）n-CH（OR2）-（CH2）nE，-（CH）=C（OR2）-（CH2）nE，-（CH2）n-CH（Y）-（CH2）mE或（CH）=C（Y）（CH2）mE;其中E是COOR3，C1-C3烷基腈，羧酰胺，磺酰胺，酰基磺酰胺或四唑，磺酰胺，酰基磺酰胺和四唑可选地与一个或多个取代基取代，独立地选自：C1-C6烷基，卤代烷基和芳基-Co-4-烷基; R2是H，脂肪基，取代脂肪基，卤代烷基，芳基，取代芳基，-COR4，-COOR4，-CONR5R6，-C（S）R4，-C（S）OR4或C（S）NR5R6，R3是H，脂肪基，取代脂肪基，芳基或取代芳基。Y是O-，CH2-，CH2CH2-或CH═CH-，并与Phenyl环A中与R1相邻的碳原子键合。R4-R6独立地是H，脂肪基，取代脂肪基，芳基或取代芳基。n和m独立地为0、1或2。
• MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS
  申请人：ELI LILLY AND COMPANY

  公开号：EP1392637A2

  公开（公告）日：2004-03-03
• US7192982B2
  申请人：——

  公开号：US7192982B2

  公开（公告）日：2007-03-20
• [EN] MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS<br/>[FR] MODULATEURS DE RECEPTEURS ACTIVES PAR LE PROLIFERATEUR DE PEROXYSOME
  申请人：LILLY CO ELI

  公开号：WO2002100813A2

  公开（公告）日：2002-12-19

  Disclosed is a compound represented by Structural Formula (I): Ar is a substituted or unsubstituted aromatic group. Q is a covalent bond, -CH2-or-CH2CH2-; W is a substituted or unsubstituted alkylene or a substituted or unsubstituted heteroalkylene linking group from two to ten atoms in length, preferably from two to seven atoms in length. Phenyl Ring A is optionally substituted with up to four substituents in addition to R1 and W. R1 is (CH2)n-CH(OR2)-(CH2)mE, -(CH)=C(OR2)-(CH2)mE, -(CH2)n-CH(Y)-(CH2)mE or (CH)=C(Y)-(CH2)mE; wherein E is COOR3, C1-C3 alkylnitrile, carboxamide, sulfonamide, acylsulfonamide or tetrazole and wherein sulfonamide, acylsulfonamide and tetrazole are optionally substituted with one or more substituents independently selected from: C1-C6 alkyl, haloalkyl and aryl-C0-4-alkyl; R2 is H, an aliphatic group, a substituted aliphatic group, haloalkyl, an aromatic group, a substituted aromatic group, -COR4, -COOR4, -CONR5R6, -C(S)R4, -C(S)OR4 or C(S)NR5R6. R3 is H, an aliphatic group, a substituted aliphatic group, an aromatic group or a substituted aromatic group. Y is O-, CH2-, -CH2CH2- or CH=CH- and is bonded to a carbon atom in Phenyl Ring A that is ortho to R1. R4-R6 are independently H, an aliphatic group, a substituted aliphatic group, an aromatic group or a substituted aromatic group. n and m are independently 0, 1 or 2.
• Rh^III -Catalyzed Decarboxylative <i>o</i> -Acylation of Arenes Bearing an Oxidizing Directing Group
  作者：Suvankar Bera、K. Chandrasekhar、Satadru Chatterjee、Sunil Kumar Killi、Debabrata Sarkar、Biswadip Banerji

  DOI：10.1002/ejoc.201900242

  日期：2019.6.30

  report of RhIII‐Catalyzed Decarboxylative Acylation of arenes. This method provides an efficient access to both of mono/bis‐ortho acylated phenols selectively. In general, for para‐substituted N‐aryloxyacetamides, the product selectivity towards mono and bis‐acylated phenols can be controlled by varying the amount of oxidant. But ortho‐ and meta‐substituted N‐aryloxyacetamides give exclusive mono‐acylated

  我们提出了Rh III催化的芳烃脱羧酰化的第一份报告。这种方法可以有效地选择性地获得单/双邻位酰化苯酚。通常，对于对位取代的N-芳氧基乙酰胺，可以通过改变氧化剂的量来控制产物对单酰化和双酰化苯酚的选择性。但是在任何条件下，邻位和间位取代的N-芳氧基乙酰胺都可以提供独家的单酰化产物。